PHGE · BiomX Inc.
$0.18
0.00 (-0.22%)
At close · Jul 29
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“substantial doubt about our ability to continue as a going concern”View the 10-Q filed May 20, 2026
Market Cap
$1.86M
Shares
10.15M
BiomX Inc. Earnings Call Transcripts
Every quarterly earnings call for BiomX Inc. (PHGE) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY25 · Q3
2025-11-12
BiomX Inc. Q3 FY2025 Earnings Call
Positive tone
FDA clinical hold on nebulizer
Regulatory engagement and Phase III pathway
BX004 Phase IIb in cystic fibrosis / Pseudomonas
Diluted EPS
$5.51
Audio
Transcript
Slides
8-K10-Q
Annual General Meeting
Investor event
2025-10-16
2025 Annual Meeting of Stockholders
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q2
2025-08-13
BiomX Inc. Q2 FY2025 Earnings Call
Confident tone
BX004 Phase IIb cystic fibrosis trial
FDA regulatory engagement and real-world evidence
BX211 diabetic foot osteomyelitis program
Diluted EPS
$3.61
▼ 72.5% YoY
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-15
BiomX Inc. Q1 FY2025 Earnings Call
Confident tone
BX211 / DFO Phase 2 Results
Financing & Cash Runway
R&D Expenses & Net Loss
Diluted EPS
$6.27
▼ 88.1% YoY
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-25
BiomX Inc. Q4 FY2024 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-14
BiomX Inc. Q3 FY2024 Earnings Call
Positive tone
BX211 DFO Phase 2 trial
BX004 CF program and manufacturing delays
Phage therapy platform
Diluted EPS
$-5.89
▼ 123.8% YoY
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
BiomX Inc. Q2 FY2024 Earnings Call
Confident tone
BX211 / Diabetic Foot Osteomyelitis Program
BX004 / Cystic Fibrosis Program
APT Merger and Financing
Diluted EPS
$13.11
▼ 42.5% YoY
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-03
BiomX Inc. Q1 FY2024 Earnings Call
Confident tone
BX004 cystic fibrosis program
BX211 diabetic foot osteomyelitis
APT merger and integration
Diluted EPS
$52.82
▲ 39% YoY
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
BiomX Inc. Q4 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-14
BiomX Inc. Q3 FY2023 Earnings Call
Diluted EPS
$24.70
▼ 43.5% YoY
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
BiomX Inc. Q2 FY2023 Earnings Call
Diluted EPS
$22.80
▼ 52% YoY
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
BiomX Inc. Q1 FY2023 Earnings Call
Diluted EPS
$38.00
▼ 25.9% YoY
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-29
BiomX Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-09
BiomX Inc. Q3 FY2022 Earnings Call
Diluted EPS
$43.70
▼ 37.8% YoY
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
BiomX Inc. Q2 FY2022 Earnings Call
Diluted EPS
$47.50
▼ 16.7% YoY
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
BiomX Inc. Q1 FY2022 Earnings Call
Diluted EPS
$51.30
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-30
BiomX Inc. Q4 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-15
BiomX Inc. Q3 FY2021 Earnings Call
Diluted EPS
$70.30
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-16
BiomX Inc. Q2 FY2021 Earnings Call
Diluted EPS
$57.00
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-24
BiomX Inc. Q1 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-31
BiomX Inc. Q4 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-12
BiomX Inc. Q3 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-13
BiomX Inc. Q2 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-14
BiomX Inc. Q1 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–24 of 24 earnings calls